Skip header and navigation

Narrow By

51 records – page 2 of 3.

Eye infections in newborns caused by gonorrhea and chlamydia

https://libcat.nshealth.ca/en/permalink/chpams36641
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2050
Available Online
View Pamphlet
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Ophthalmia Neonatorum - prevention & control
Subjects (LCSH)
Conjunctivitis, Infantile
Specialty
Gynecology
Abstract
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you can prevent your newborn from getting an eye infection caused by gonorrhea or chlamydia, how to know if your baby has an eye infection, and what to do if you think your newborn may have an eye infection. Resources for more information are included.
Responsibility
Prepared by: Women and Children’s Provincial Policy Working Group
Pamphlet Number
2050
Less detail

Getting enough iron during pregnancy

https://libcat.nshealth.ca/en/permalink/chpams38168
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2330
Available Online
View Pamphlet
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included fo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Iron, Dietary
Pregnancy
Subjects (LCSH)
Iron in human nutrition
Pregnancy
Specialty
Gynecology
Abstract
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included for your health care team to record your hemoglobin and ferritin levels. Instructions on how to take elemental iron are given.
Responsibility
Prepared by: OBS Clinic, South Shore Regional Hospital
Pamphlet Number
2330
Less detail

High blood pressure in pregnancy - South Shore Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams37588
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children's Health Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2285
Available Online
View Pamphlet
High blood pressure in pregnancy (also called gestational hypertension) is a blood pressure (BP) that stays higher than 140/90 (140 over 90). For most people, a normal blood pressure is 140/90 or less. After week 20 of your pregnancy, high blood pressure can be linked to pre-eclampsia. This is a more serious condition that includes high blood pressure and protein in the urine (pee). Because pre-eclampsia can be dangerous to you and your baby, we ask you to monitor your blood pressure and sympto…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children's Health Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Hypertension
Pregnancy
Subjects (LCSH)
Hypertension
Pregnancy
Specialty
Gynecology
Abstract
High blood pressure in pregnancy (also called gestational hypertension) is a blood pressure (BP) that stays higher than 140/90 (140 over 90). For most people, a normal blood pressure is 140/90 or less. After week 20 of your pregnancy, high blood pressure can be linked to pre-eclampsia. This is a more serious condition that includes high blood pressure and protein in the urine (pee). Because pre-eclampsia can be dangerous to you and your baby, we ask you to monitor your blood pressure and symptoms. This pamphlet explains the symptoms to watch for if you have high blood pressure, how to check your blood pressure at home, and symptoms that require medical attention right away. Contact information for the OBS Clinic and OBS Unit, and sheets to keep track of your blood pressure are included.
Responsibility
Prepared by: South Shore Regional Hospital, Women and Children’s Health Program
Pamphlet Number
2285
Less detail

How anxiety and your mood may change in pregnancy and after birth

https://libcat.nshealth.ca/en/permalink/chpams38175
Nova Scotia Health Authority. Western Zone. Perinatal Mental Health Initiative, Nova Scotia Perinatal Mental Health Alliance and affiliates. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2336
Available Online
View Pamphlet
This pamphlet gives information on common issues, like sleep troubles and intrusive thoughts (strange thoughts or mental images that seem to pop into your head and cause stress), anxiety and mood disorders, and postpartum psychosis (rare). Topics include what to do if you had a mental disorder before you became pregnant, what Baby Blues are and how to get ready for them, and what to do if you still feel overwhelmed, irritable, stressed, or sad after 2 to 4 weeks. Information on how to get help …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Western Zone. Perinatal Mental Health Initiative
Nova Scotia Perinatal Mental Health Alliance and affiliates
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (16 p.) : digital, PDF file
Subjects (MeSH)
Pregnant Women - psychology
Anxiety
Mood Disorders - diagnosis
Postnatal Care
Subjects (LCSH)
Pregnancy--Psychological aspects
Anxiety
Mental health
Postnatal care
Specialty
Gynecology
Abstract
This pamphlet gives information on common issues, like sleep troubles and intrusive thoughts (strange thoughts or mental images that seem to pop into your head and cause stress), anxiety and mood disorders, and postpartum psychosis (rare). Topics include what to do if you had a mental disorder before you became pregnant, what Baby Blues are and how to get ready for them, and what to do if you still feel overwhelmed, irritable, stressed, or sad after 2 to 4 weeks. Information on how to get help with your mood or anxiety, and what to do if you have thoughts of self-harm or suicide is given. A list of resources is included.
Responsibility
Prepared by: Perinatal Mental Health Initiative, Western Zone, in collaboration with Nova Scotia Perinatal Mental Health Alliance and affiliates; Adapted from: Bussey, L., & Williams, A. (2022). Primary care perinatal mental health toolkit. Dalhousie Departments of Psychiatry & Family Medicine. http://rcp.nshealth.ca/sites/default/files/Primary%20Care%20Perinatal%20Mental%20Health%20Toolkit_2022.pdf and Perinatal Services BC. (2014). Best practices guidelines for mental health disorders in the perinatal period http://www.perinatalservicesbc.ca/Documents/Guidelines-Standards/Maternal/MentalHealthDisordersGuideline.pdf
Pamphlet Number
2336
Less detail

How to apply your steroid ointment

https://libcat.nshealth.ca/en/permalink/chpams35603
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1607
Available Online
View Pamphlet
You have been prescribed a steroid ointment. This medication helps to lower inflammation (redness, swelling, pain) caused by a skin condition on your vulva. This 1-page sheet explains how to apply (put) your steroid ointment on your vulva. A diagram shows exactly where to apply the ointment. Tips to remember are included. The French version of this pamphlet 2111, "Comment appliquer votre onguent stéroïde", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Diseases - drug therapy
Steroids - therapeutic use
Subjects (LCSH)
Steroid drugs
Vulva--Diseases
Specialty
Gynecology
Abstract
You have been prescribed a steroid ointment. This medication helps to lower inflammation (redness, swelling, pain) caused by a skin condition on your vulva. This 1-page sheet explains how to apply (put) your steroid ointment on your vulva. A diagram shows exactly where to apply the ointment. Tips to remember are included. The French version of this pamphlet 2111, "Comment appliquer votre onguent stéroïde", is also available.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
1607
Less detail

Hystérectomie laparoscopique

https://libcat.nshealth.ca/en/permalink/chpams36454
Nova Scotia Health Authority. Gynaecology. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1896
Available Online
View Pamphlet
Une hystérectomie laparoscopique est une chirurgie qui permet d’enlever l’utérus et le col de l’utérus en passant par le vagin. Les ovaires et les trompes de Fallope sont souvent enlevés en même temps. Après la chirurgie, vous aurez une intraveineuse (IV), un cathéter (tube) pour vider la vessie de son urine et un pansement sur l’abdomen (le ventre). La présente brochure traite de la respiration, du traitement de la douleur, des saignements vaginaux, des soins des incisions, des caillots de san…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Gynaecology
Alternate Title
Laparoscopic hysterectomy
Laparoscopy assisted vaginal hysterectomy
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Hysterectomy
Postoperative Care
Subjects (LCSH)
Hysterectomy
Postoperative care
Specialty
Gynecology
Abstract
Une hystérectomie laparoscopique est une chirurgie qui permet d’enlever l’utérus et le col de l’utérus en passant par le vagin. Les ovaires et les trompes de Fallope sont souvent enlevés en même temps. Après la chirurgie, vous aurez une intraveineuse (IV), un cathéter (tube) pour vider la vessie de son urine et un pansement sur l’abdomen (le ventre). La présente brochure traite de la respiration, du traitement de la douleur, des saignements vaginaux, des soins des incisions, des caillots de sang et de votre cycle menstruel. De l’information est aussi fournie sur les soins à dispenser à domicile et les rapports sexuels après la chirurgie. Les symptômes exigeant des soins médicaux sont indiqués.
This pamphlet is a French translation of "Laparoscopic Hysterectomy" pamphlet 0434. A laparoscopic hysterectomy is an operation to remove your uterus (womb) and cervix through your vagina. The ovaries and fallopian tubes are often taken out at the same time. After surgery you will have an intravenous (IV), a catheter (tube) to drain urine from your bladder, and a dressing on your abdomen (stomach area). Topics in this pamphlet include breathing, managing pain, vaginal bleeding, incision care, blood clots and your menstrual cycle. Information on care at home and sex after surgery is provided. Symptoms that require medical attention are given.
Responsibility
Prepared by: Angela Whynot, Nurse Educator
Pamphlet Number
1896
Less detail

Induction of labour

https://libcat.nshealth.ca/en/permalink/chpams35818
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1768
Available Online
View Pamphlet
Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed. The French version of this pamphlet 1813, "Déclenchement artificiel du travail", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed. The French version of this pamphlet 1813, "Déclenchement artificiel du travail", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1768
Less detail

Induction of labour and cervical ripening with balloon catheter

https://libcat.nshealth.ca/en/permalink/chpams35819
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1769
Available Online
View Pamphlet
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1769
Less detail

Induction of labour and cervical ripening with dinoprostone vaginal insert (Cervidil)

https://libcat.nshealth.ca/en/permalink/chpams35820
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1770
Available Online
View Pamphlet
Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital. The French version of this pamphlet 1815, "Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dino…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with dinoprostone vaginal insert (Cervidil)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital. The French version of this pamphlet 1815, "Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dinoprostone (Cervidil®)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1770
Less detail

Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35821
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1771
Available Online
View Pamphlet
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de c…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec®)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1771
Less detail

Information for Female Patients Receiving Radiation Therapy Treatment to the Pelvis

https://libcat.nshealth.ca/en/permalink/chpams37406
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1337
Available Online
View Pamphlet
This pamphlets provides information for patients receiving radiation therapy to the pelvis. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Female
Pelvic Neoplasms - radiotherapy
Urogenital Neoplasms - radiotherapy
Subjects (LCSH)
Genitourinary organs--Cancer--Radiotherapy
Pelvis--Cancer--Radiotherapy
Self-care, Health
Specialty
Gynecology
Radiotherapy
Abstract
This pamphlets provides information for patients receiving radiation therapy to the pelvis. Answers common questions like: what will happen during your treatment, how long are the treatments, and what are the possible side effects of radiation therapy.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1337
Less detail

Interaction des contraceptifs avec le sugammadex (Bridion™)

https://libcat.nshealth.ca/en/permalink/chpams37519
Nova Scotia Health Authority. QEII. Department of Anesthesia. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2202
Available Online
View Pamphlet
Pendant votre chirurgie, vous avez reçu un médicament qui diminue l’efficacité de certaines méthodes de contraception hormonale. Le sugammadex (Bridion) a été utilisé pour inverser les effets du relaxant musculaire qu’on vous a administré pendant votre chirurgie. Il peut réduire l’efficacité des contraceptifs hormonaux pendant 7 jours (une semaine). Vous devez donc utiliser une méthode de contraception additionnelle pendant 7 jours après votre chirurgie. ; This pamphlet is a French translation …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Department of Anesthesia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Sugammadex - adverse effects
Hormonal Contraception
Subjects (LCSH)
Sugammadex
Specialty
Gynecology
Abstract
Pendant votre chirurgie, vous avez reçu un médicament qui diminue l’efficacité de certaines méthodes de contraception hormonale. Le sugammadex (Bridion) a été utilisé pour inverser les effets du relaxant musculaire qu’on vous a administré pendant votre chirurgie. Il peut réduire l’efficacité des contraceptifs hormonaux pendant 7 jours (une semaine). Vous devez donc utiliser une méthode de contraception additionnelle pendant 7 jours après votre chirurgie.
This pamphlet is a French translation of "Birth Control medication Interaction with Sugammadex (Bridion™)" pamphlet 2076. During your surgery, you received medication that affects how well birth control medications work. You need to be aware of this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion™) is a medication that helps to speed up recovery from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for up to 7 days (1 week). You must use a back-up birth control method for 7 days after your surgery.
Responsibility
Prepared by: Department of Anesthesia
Pamphlet Number
2202
Less detail

Internal and external condoms

https://libcat.nshealth.ca/en/permalink/chpams37442
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1039
Available Online
View Pamphlet
Condoms are birth control devices that prevent semen (the fluid that contains sperm) from entering a vagina or anus. When semen is released inside a vagina, it may reach an egg and fertilize it, causing pregnancy. Condoms also help prevent the spread of sexually transmitted infections (STIs), including HIV, if used properly. There are 2 types of condoms: internal (worn on the inside of the vagina or anus) and external (worn on the outside of an erect penis). This pamphlet explains what internal…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Contraception - methods
Subjects (LCSH)
Contraception
Specialty
Gynecology
Abstract
Condoms are birth control devices that prevent semen (the fluid that contains sperm) from entering a vagina or anus. When semen is released inside a vagina, it may reach an egg and fertilize it, causing pregnancy. Condoms also help prevent the spread of sexually transmitted infections (STIs), including HIV, if used properly. There are 2 types of condoms: internal (worn on the inside of the vagina or anus) and external (worn on the outside of an erect penis). This pamphlet explains what internal and external condoms are, how they work, how well they work to prevent pregnancy, what to do if a condom breaks during vaginal sex, and what to do if your partner does not want to use a condom. A link to the The Society of Obstetricians and Gynaecologists of Canada website is provided for further information.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1039
Less detail

Laparoscopic hysterectomy

https://libcat.nshealth.ca/en/permalink/chpams35900
Nova Scotia Health Authority. Gynaecology. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
0434
Available Online
View Pamphlet
A laparoscopic hysterectomy is an operation to remove your uterus (womb) and cervix through your vagina. The ovaries and fallopian tubes are often taken out at the same time. After surgery you will have an intravenous (IV), a catheter (tube) to drain urine from your bladder, and a dressing on your abdomen (stomach area). Topics in this pamphlet include breathing, managing pain, vaginal bleeding, incision care, blood clots and your menstrual cycle. Information on care at home and sex after surge…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Gynaecology
Alternate Title
Laparoscope assisted vaginal hysterectomy
Laparoscopy assisted vaginal hysterectomy
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Hysterectomy
Postoperative Care
Subjects (LCSH)
Hysterectomy
Postoperative care
Specialty
Gynecology
Abstract
A laparoscopic hysterectomy is an operation to remove your uterus (womb) and cervix through your vagina. The ovaries and fallopian tubes are often taken out at the same time. After surgery you will have an intravenous (IV), a catheter (tube) to drain urine from your bladder, and a dressing on your abdomen (stomach area). Topics in this pamphlet include breathing, managing pain, vaginal bleeding, incision care, blood clots and your menstrual cycle. Information on care at home and sex after surgery is provided. Symptoms that require medical attention are given. The French version of this pamphlet 1896, "Hystérectomie laparoscopique", is also available.
Responsibility
Prepared by: Angela Whynot, Nurse Educator
Pamphlet Number
0434
Less detail

Lichen sclerosus

https://libcat.nshealth.ca/en/permalink/chpams35457
Nova Scotia Health Authority. QEII. Colposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1529
Available Online
View Pamphlet
Lichen sclerosus is a life-long condition that creates patchy white areas of the skin. It may affect any part of the body, but it most often involves the skin of the vulva (opening to the vagina) and around the anus. This pamphlet explains the causes, symptoms, diagnosis, treatment, follow-up care, and contact information for the Colposcopy Clinic.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Colposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Lichen Sclerosus et Atrophicus
Skin Diseases, Papulosquamous
Subjects (LCSH)
Vulva--Diseases
Skin--Diseases
Specialty
Gynecology
Abstract
Lichen sclerosus is a life-long condition that creates patchy white areas of the skin. It may affect any part of the body, but it most often involves the skin of the vulva (opening to the vagina) and around the anus. This pamphlet explains the causes, symptoms, diagnosis, treatment, follow-up care, and contact information for the Colposcopy Clinic.
Responsibility
Prepared by: Colposcopy Clinic
Pamphlet Number
1529
Less detail

Maturation cervicale au moyen du gel vaginal de dinoprostone (Prostin)

https://libcat.nshealth.ca/en/permalink/chpams35881
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1817
Available Online
View Pamphlet
ProstinMD est un gel. Il contient un médicament appelé dinoprostone (prostaglandine E2). La dinoprostone PGE2 (ou gel ProstinMD) est comme une substance naturelle produite par votre corps. Elle assouplit le col de l’utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation du gel ProstinMD, les complications possibles et quand appeler l’hôpital ou y retourner. ; This pamphlet is a French translation of "Cervical Ripening with Dinoprostone …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor, Induced (Obstetrics)
Specialty
Gynecology
Abstract
ProstinMD est un gel. Il contient un médicament appelé dinoprostone (prostaglandine E2). La dinoprostone PGE2 (ou gel ProstinMD) est comme une substance naturelle produite par votre corps. Elle assouplit le col de l’utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation du gel ProstinMD, les complications possibles et quand appeler l’hôpital ou y retourner.
This pamphlet is a French translation of "Cervical Ripening with Dinoprostone Vaginal Gel (Prostin®)" pamphlet 1772. Prostin® is a gel. It contains medication called dinoprostone (prostaglandin E2). Dinoprostone PGE2 (or Prostin®) is like a natural substance made by your body. It softens the cervix to get it ready for labour. This pamphlet explains what to expect when you get Prostin®, possible complications of Prostin®, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health
Pamphlet Number
1817
Less detail

Medical abortion

https://libcat.nshealth.ca/en/permalink/chpams35888
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1831
Available Online
View Pamphlet
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1831
Less detail

Medical abortion (Mifegymiso) instructions

https://libcat.nshealth.ca/en/permalink/chpams35935
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1878
Available Online
View Pamphlet
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1878
Less detail
Nova Scotia Health Authority. QEII. Gynaecology. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1553
Available Online
View Pamphlet
A molar pregnancy is a rare condition that can happen during pregnancy. It is part of a number of conditions that together are called gestation trophoblastic disease (GTD). This pamphlet explains what causes a molar pregnancy, who can get it, diagnosis, treatment, test results, as well as answering questions you may have about getting pregnant again after experiencing a molar pregnancy. If you have any questions, a contact number is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Gynaecology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Hydatidiform Mole
Gestational Trophoblastic Disease
Subjects (LCSH)
Molar pregnancy
Gestational trophoblastic disease
Specialty
Gynecology
Abstract
A molar pregnancy is a rare condition that can happen during pregnancy. It is part of a number of conditions that together are called gestation trophoblastic disease (GTD). This pamphlet explains what causes a molar pregnancy, who can get it, diagnosis, treatment, test results, as well as answering questions you may have about getting pregnant again after experiencing a molar pregnancy. If you have any questions, a contact number is provided.
Responsibility
Prepared by: Department of Obstetrics and Gynaecology
Pamphlet Number
1553
Less detail

Neonatal abstinence syndrome

https://libcat.nshealth.ca/en/permalink/chpams36769
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2144
Available Online
View Pamphlet
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2144
Less detail

51 records – page 2 of 3.